secwatch.observer — SEC 8-K summary
======================================

Issuer:     RETRACTABLE TECHNOLOGIES INC (RVP)
CIK:        0000946563
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001104659-25-112393
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Retractable Q3 net sales $10.1M, operating loss $3.7M; receives Vizient designation
--------------------------------------------------------------------------------

- Q3 net sales $10.1M (down from $10.3M YoY); operating loss $3.7M vs $5.1M loss last year.
- Net income $371k in Q3 includes $2.4M unrealized gains on securities; 9-month net loss $10.2M.
- Tariffs on needles from China at 130%; $2.3M spent on tariffs in first nine months of 2025.
- U.S. manufacturing share rose to 38.3% in 2025 from 10% in 2024; workforce reductions implemented.
- EasyPoint Blood Collection Tube Holder with Needle received Vizient Innovative Technology designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946563/000110465925112393/0001104659-25-112393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946563/000110465925112393/tm2531255d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-112393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer